Andelyn Biosciences and Evolyra Therapeutics Join Forces to Advance Gene Therapy Manufacturing for Rare Muscle Diseases Andelyn Biosciences has partnered with Evolyra Therapeutics to manufacture innovative AAV gene therapies targeting Limb-Girdle Muscular Dystrophies, enhancing treatment options for patients.

Andelyn Biosciences and Evolyra Therapeutics Join Forces to Advance Gene Therapy Manufacturing for Rare Muscle Diseases #United_States #Columbus #Andelyn_Biosciences #Evolyra_Therapeutics #Limb-Girdle_Muscular_Dystrophy

Andelyn Biosciences Launches Foundation to Assist Families Facing Rare Diseases Andelyn Biosciences has established the Andelyn Foundation, a nonprofit aimed at supporting families dealing with rare diseases through community fundraising and awareness initiatives.

Andelyn Biosciences Launches Foundation to Assist Families Facing Rare Diseases #United_States #Columbus #Rare_Diseases #Andelyn_Biosciences #Andelyn_Foundation

Andelyn Biosciences Forms Partnership with Jaguar for Phelan-McDermid Syndrome Gene Therapy Andelyn Biosciences and Jaguar Gene Therapy have announced a collaboration to advance JAG201, a new gene therapy targeting Phelan-McDermid syndrome.

Andelyn Biosciences Forms Partnership with Jaguar for Phelan-McDermid Syndrome Gene Therapy #United_States #Columbus #Andelyn_Biosciences #Jaguar_Gene_Therapy #Phelan-McDermid_Syndrome

Andelyn Biosciences Collaborates with Tern Therapeutics to Tackle CLN2 Batten Disease with AAV Gene Therapy Andelyn Biosciences teams up with Tern Therapeutics for late-stage manufacturing of AAV gene therapy aimed at curing CLN2 Batten disease, offering hope for affected children.

Andelyn Biosciences Collaborates with Tern Therapeutics to Tackle CLN2 Batten Disease with AAV Gene Therapy #USA #Columbus #Andelyn_Biosciences #AAV_Gene_Therapy #CLN2_Batten_Disease

Andelyn Biosciences and Amplo Biotechnology Join Forces for Gene Therapy Manufacturing Andelyn Biosciences and Amplo Biotechnology have partnered to manufacture gene therapies targeting neuromuscular diseases, improving patient outcomes and advancing clinical trials.

Andelyn Biosciences and Amplo Biotechnology Join Forces for Gene Therapy Manufacturing #United_States #Columbus #gene_therapy #Andelyn_Biosciences #Amplo_Biotechnology

Andelyn Biosciences Achieves Milestone in Gene Therapy for Rare Disease After 14 Months of Determined Efforts Andelyn Biosciences has successfully delivered a novel gene therapy for an ultra-rare disease, marking a significant milestone in medical advancements and patient care.

Andelyn Biosciences Achieves Milestone in Gene Therapy for Rare Disease After 14 Months of Determined Efforts #United_States #Columbus #Andelyn_Biosciences #Elly's_Team #NEDAMSS

Andelyn Biosciences Revolutionizes CAR-NK Cell Therapy with Innovative AAV Curator® Platform for AML Treatment Andelyn Biosciences has successfully utilized its AAV Curator® Platform to produce viral vectors for pioneering CAR-NK cell therapy targeting AML, set for a clinical trial.

Andelyn Biosciences Revolutionizes CAR-NK Cell Therapy with Innovative AAV Curator® Platform for AML Treatment #USA #Columbus #Andelyn_Biosciences #CAR-NK_Cells #AAV_Curator

Andelyn Biosciences Enhances Gene Therapy Options with New CNS Capsids from Broad Institute Andelyn Biosciences has expanded its AAV Curator Platform by incorporating CNS capsids from the Broad Institute, enhancing gene therapy for nervous disorders.

Andelyn Biosciences Enhances Gene Therapy Options with New CNS Capsids from Broad Institute #USA #Columbus #Broad_Institute #Andelyn_Biosciences #CNS_Capsids